When does the metformin hydrochloride (HCl) patent expire?
“Metformin hydrochloride” is a long-established generic medicine. The original patents tied to the drug substance and early branded formulations have already expired in most jurisdictions, which is why metformin is widely available as inexpensive generics.
If you’re trying to pinpoint an exact “patent expiry date” for a particular country or a specific product (not the molecule generally), you need the exact patent record (assignee, patent number, jurisdiction, and formulation/brand). Patent listings also differ for:
- the original drug substance (metformin HCl),
- specific salt forms/formulations,
- extended-release versions (often handled under different IP families),
- and any later “life-cycle” patents (combination products, manufacturing processes, etc.).
A practical place to start for tracking the specific patent(s) and their scheduled end dates by product/market is DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “metformin hydrochloride”).
What is the half-life of metformin (metformin hydrochloride)?
Metformin’s elimination half-life is commonly reported as roughly 4–8 hours in adults, with the drug cleared largely by the kidneys (renal excretion).
That half-life means metformin generally requires multiple daily dosing depending on the formulation (immediate-release versus extended-release).
What therapeutic area is metformin hydrochloride used in?
Metformin hydrochloride is used in the therapeutic area of:
- type 2 diabetes mellitus (T2DM), where it is often a first-line therapy,
and it can also be used in related metabolic/diabetes-prevention settings depending on local clinical guidance.
Does metformin’s patent situation differ for immediate-release vs extended-release?
Yes. Even though the active ingredient is the same (metformin), extended-release (often marketed separately) can have different patent families tied to:
- the formulation and release mechanism,
- manufacturing/technology,
- and certain product-specific exclusivities.
So “metformin patent expiry date” can look different depending on whether you mean IR generic entry versus ER product exclusivity/patent status.
If you tell me the country and brand, can you give the exact expiry date?
If you share:
1) jurisdiction (e.g., US, EP, UK, India),
2) whether you mean IR or ER (and the brand name if relevant),
3) and any patent number or applicant/assignee,
I can help narrow down the specific patent(s) and their scheduled expiry dates using the right records (including via DrugPatentWatch.com).
Sources
- https://www.drugpatentwatch.com/